2001
DOI: 10.1034/j.1600-0463.2001.091211.x
|View full text |Cite
|
Sign up to set email alerts
|

Intranodal benign thyroid tissue: Significance of HBME‐1 in differentiation from metastatic papillary thyroid carcinoma

Abstract: The aim of this study was to determine the significance of HBME-1 immunostaining in the differentiation between intranodal benign thyroid tissue and metastatic papillary thyroid carcinoma in the lymph node. Immunohistochemically we examined normal-appearing intranodal thyroid tissue in four patients who did not show evidence of papillary carcinoma histologically or clinically. We also examined follicular-pattern-predominant papillary carcinoma with metastatic foci in the lymph nodes. Normal-appearing intranoda… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 8 publications
1
1
0
Order By: Relevance
“…All papillary carcinomas demonstrated positivity for HBME-1 in both the thyroid and lymph nodes, which corresponds to the observation of Torregossa et al [21] and Hirokawa et al [22]. Even more, in this study 82.4 % of primary tumours and their LNMs were highly HBME-1 positive.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…All papillary carcinomas demonstrated positivity for HBME-1 in both the thyroid and lymph nodes, which corresponds to the observation of Torregossa et al [21] and Hirokawa et al [22]. Even more, in this study 82.4 % of primary tumours and their LNMs were highly HBME-1 positive.…”
Section: Discussionsupporting
confidence: 90%
“…Also, there is poor information about HBME-1 immunostaining in PTC metastases in lymph nodes. According to the occasional studies, all LNM of papillary carcinomas show strong HBME-1 positivity [21,22]. In addition, the few results concerning the association of HBME-1 expression with prognostic clinicopathological factors in thyroid carcinoma patients are controversial [9,23,24].…”
Section: Introductionmentioning
confidence: 99%